Safety Profile and Side Effects Retatrutides side effect profile in Phase 2 trials was broadly consistent with other GLP-1 class therapies primarily gastrointestinal, primarily dose-dependent, and primarily manageable
Franco R, Panayiotidis MI, Cidlowski JA
She will identify a safe, effective, and minimally invasive treatment to make a difference in your body shape
There are no reports on the anti-cancer effects of vildagliptin, but as DPP-IV activity itself is known to promote carcinogenesis and metastasis in a variety of cancers, including breast cancer, vildagliptin may exert anti-cancer effects through inhibition of DPP-IV (Parmar et al., 2021
Similar to AUDIT, only participants taking Semaglutide or Tirzepatide completed questions asking about prior to and while on their medication, while control group participants only answered about their current typical use